Arrestin

Last updated
S-antigen; retina and pineal gland (arrestin)
1CF1.png
Crystallographic structure of the bovine arrestin-S. [1]
Identifiers
Symbol SAG
Alt. symbolsarrestin-1
NCBI gene 6295
HGNC 10521
OMIM 181031
RefSeq NM_000541
UniProt P10523
Other data
Locus Chr. 2 q37.1
Search for
Structures Swiss-model
Domains InterPro
arrestin beta 1
Identifiers
Symbol ARRB1
Alt. symbolsARR1, arrestin-2
NCBI gene 408
HGNC 711
OMIM 107940
RefSeq NM_004041
UniProt P49407
Other data
Locus Chr. 11 q13
Search for
Structures Swiss-model
Domains InterPro
arrestin beta 2
Identifiers
Symbol ARRB2
Alt. symbolsARR2, arrestin-3
NCBI gene 409
HGNC 712
OMIM 107941
RefSeq NM_004313
UniProt P32121
Other data
Locus Chr. 17 p13
Search for
Structures Swiss-model
Domains InterPro
arrestin 3, retinal (X-arrestin)
Identifiers
Symbol ARR3
Alt. symbolsARRX, arrestin-4
NCBI gene 407
HGNC 710
OMIM 301770
RefSeq NM_004312
UniProt P36575
Other data
Locus Chr. X q
Search for
Structures Swiss-model
Domains InterPro

Arrestins (abbreviated Arr) are a small family of proteins important for regulating signal transduction at G protein-coupled receptors. [2] [3] Arrestins were first discovered as a part of a conserved two-step mechanism for regulating the activity of G protein-coupled receptors (GPCRs) in the visual rhodopsin system by Hermann Kühn, Scott Hall, and Ursula Wilden [4] and in the β-adrenergic system by Martin J. Lohse and co-workers. [5] [6]

Contents

Function

In response to a stimulus, GPCRs activate heterotrimeric G proteins. In order to turn off this response, or adapt to a persistent stimulus, active receptors need to be desensitized. The first step in desensitization is phosphorylation of the receptor by a class of serine/threonine kinases called G protein coupled receptor kinases (GRKs). GRK phosphorylation specifically prepares the activated receptor for arrestin binding. Arrestin binding to the receptor blocks further G protein-mediated signaling and targets receptors for internalization, and redirects signaling to alternative G protein-independent pathways, such as β-arrestin signaling. [7] [8] [9] [10] [6] In addition to GPCRs, arrestins bind to other classes of cell surface receptors and a variety of other signaling proteins. [11]

Subtypes

Mammals express four arrestin subtypes and each arrestin subtype is known by multiple aliases. The systematic arrestin name (1-4) plus the most widely used aliases for each arrestin subtype are listed in bold below:

Fish and other vertebrates appear to have only three arrestins: no equivalent of arrestin-2, which is the most abundant non-visual subtype in mammals, was cloned so far. The proto-chordate Ciona intestinalis (sea squirt) has only one arrestin, which serves as visual in its mobile larva with highly developed eyes, and becomes generic non-visual in the blind sessile adult. Conserved positions of multiple introns in its gene and those of our arrestin subtypes suggest that they all evolved from this ancestral arrestin. [12] Lower invertebrates, such as roundworm Caenorhabditis elegans , also have only one arrestin. Insects have arr1 and arr2, originally termed visual arrestins because they are expressed in photoreceptors, and one non-visual subtype (kurtz in Drosophila ). Later arr1 and arr2 were found to play an important role in olfactory neurons and renamed sensory. Fungi have distant arrestin relatives involved in pH sensing.

Tissue distribution

One or more arrestin is expressed in virtually every eukaryotic cell. In mammals, arrestin-1 and arrestin-4 are largely confined to photoreceptors, whereas arrestin-2 and arrestin-3 are ubiquitous. Neurons have the highest expression level of both non-visual subtypes. In neuronal precursors both are expressed at comparable levels, whereas in mature neurons arrestin-2 is present at 10-20 fold higher levels than arrestin-3.

Mechanism

Arrestins block GPCR coupling to G proteins in two ways. First, arrestin binding to the cytoplasmic face of the receptor occludes the binding site for heterotrimeric G-protein, preventing its activation (desensitization). [13] Second, arrestin links the receptor to elements of the internalization machinery, clathrin and clathrin adaptor AP2, which promotes receptor internalization via coated pits and subsequent transport to internal compartments, called endosomes. Subsequently, the receptor could be either directed to degradation compartments (lysosomes) or recycled back to the plasma membrane where it can again signal. The strength of arrestin-receptor interaction plays a role in this choice: tighter complexes tend to increase the probability of receptor degradation (Class B), whereas more transient complexes favor recycling (Class A), although this rule is far from absolute. [2] More recently direct interactions between Gi/o family G proteins and Arrestin were discovered downstream of multiple receptors, regardless of canonical G protein coupling. [14] These recent findings introduce a GPCR signaling mechanism distinct from canonical G protein activation and β-arrestin desensitization in which GPCRs cause the formation of Gαi:β-arrestin signaling complexes.

Structure

Arrestins are elongated molecules, in which several intra-molecular interactions hold the relative orientation of the two domains. Unstimulated cell arrestins are localized in the cytoplasm in a basal inactive conformation. Active phosphorylated GPCRs recruit arrestin to the plasma membrane. Receptor binding induces a global conformational change that involves the movement of the two arrestin domains and the release of its C-terminal tail that contains clathrin and AP2 binding sites. Increased accessibility of these sites in receptor-bound arrestin targets the arrestin-receptor complex to the coated pit. Arrestins also bind microtubules (part of the cellular skeleton), where they assume yet another conformation, different from both free and receptor-bound form. Microtubule-bound arrestins recruit certain proteins to the cytoskeleton, which affects their activity and/or redirects it to microtubule-associated proteins.

Arrestins shuttle between cell nucleus and cytoplasm. Their nuclear functions are not fully understood, but it was shown that all four mammalian arrestin subtypes remove some of their partners, such as protein kinase JNK3 or the ubiquitin ligase Mdm2, from the nucleus. Arrestins also modify gene expression by enhancing transcription of certain genes.

Application

S-Arrestin is a protein found in mice that binds to rhodopsin to stop its activity, preventing further signaling. S-arrestin binds to G protein-coupled receptors (GPCRs), like rhodopsin, following receptor activation and phosphorylation by G protein-coupled receptor kinases (GRKs). Rhodopsin is found in rod cells of the retina, essential for vision. It detects light and initiates a signaling cascade called phototransduction. However, excessive activation can be harmful, so it must be carefully regulated.The phosphorylation of the receptor's intracellular loops and C-terminal tail creates a high-affinity binding site for S-arrestin. S-arrestin then sterically hinders further G protein coupling, effectively desensitizing the receptor and directing it towards alternative signaling pathways or internalization via clathrin-mediated endocytosis.

How Arrestin Binds to Rhodopsin

The binding of S-arrestin to rhodopsin is specific and involves changes that occur in rhodopsin after activation. Important serine (Ser) and threonine (Thr) residues in rhodopsin's tail, particularly Thr-340 and Ser-343, are phosphorylated by enzymes called GRKs. These phosphorylated residues strongly attract S-arrestin, helping it bind tightly and effectively shut down rhodopsin’s signaling [15] .

Additionally, studies of the protein structure have shown that during activation, rhodopsin's transmembrane helix 7 (TM7) and helix 8 change shape. These changes expose a binding site that interacts with a specific part of arrestin called the "finger loop." This interaction, clearly seen in the crystal structure (PDB ID: 4ZWJ), shows how arrestin fits precisely onto activated and phosphorylated rhodopsin, efficiently stopping the visual signal [16] .

Crystal structure showing where arrestin will precisely bound to activated and phosphorylated rhodopsin at key residues Rhodopsin Binding Site for Arrestin.jpg
Crystal structure showing where arrestin will precisely bound to activated and phosphorylated rhodopsin at key residues
Arrestin (or S-antigen), N-terminal domain
PDB 1cf1 EBI.jpg
Structure of arrestin from bovine rod outer segments. [1]
Identifiers
SymbolArrestin_N
Pfam PF00339
Pfam clan CL0135
InterPro IPR011021
PROSITE PDOC00267
SCOP2 1cf1 / SCOPe / SUPFAM
Available protein structures:
Pfam   structures / ECOD  
PDB RCSB PDB; PDBe; PDBj
PDBsum structure summary
PDB 1ayr , 1cf1 , 1g4m , 1g4r , 1jsy , 1zsh
Arrestin (or S-antigen), C-terminal domain
PDB 1g4m EBI.jpg
Structure of bovine beta-arrestin. [17]
Identifiers
SymbolArrestin_C
Pfam PF02752
Pfam clan CL0135
InterPro IPR011022
SCOP2 1cf1 / SCOPe / SUPFAM
Available protein structures:
Pfam   structures / ECOD  
PDB RCSB PDB; PDBe; PDBj
PDBsum structure summary
PDB 1ayr , 1cf1 , 1g4m , 1g4r , 1jsy , 1suj , 1zsh

References

  1. 1 2 PDB: 1CF1 ; Hirsch JA, Schubert C, Gurevich VV, Sigler PB (April 1999). "The 2.8 A crystal structure of visual arrestin: a model for arrestin's regulation". Cell. 97 (2): 257–69. doi: 10.1016/S0092-8674(00)80735-7 . PMID   10219246. S2CID   17124300.
  2. 1 2 Moore CA, Milano SK, Benovic JL (2007). "Regulation of receptor trafficking by GRKs and arrestins". Annual Review of Physiology. 69: 451–82. doi:10.1146/annurev.physiol.69.022405.154712. PMID   17037978.
  3. Lefkowitz RJ, Shenoy SK (April 2005). "Transduction of receptor signals by beta-arrestins". Science. 308 (5721): 512–7. Bibcode:2005Sci...308..512L. doi:10.1126/science.1109237. PMID   15845844. S2CID   26931077.
  4. Wilden U, Hall SW, Kühn H (March 1986). "Phosphodiesterase activation by photoexcited rhodopsin is quenched when rhodopsin is phosphorylated and binds the intrinsic 48-kDa protein of rod outer segments". Proceedings of the National Academy of Sciences of the United States of America. 83 (5): 1174–8. Bibcode:1986PNAS...83.1174W. doi: 10.1073/pnas.83.5.1174 . PMC   323037 . PMID   3006038.
  5. Lohse MJ, Benovic JL, Codina J, Caron MG, Lefkowitz RJ (June 1990). "beta-Arrestin: a protein that regulates beta-adrenergic receptor function". Science. 248 (4962): 1547–50. Bibcode:1990Sci...248.1547L. doi:10.1126/science.2163110. PMID   2163110.
  6. 1 2 Gurevich VV, Gurevich EV (June 2006). "The structural basis of arrestin-mediated regulation of G-protein-coupled receptors". Pharmacology & Therapeutics. 110 (3): 465–502. doi:10.1016/j.pharmthera.2005.09.008. PMC   2562282 . PMID   16460808.
  7. Smith JS, Lefkowitz RJ, Rajagopal S (January 2018). "Biased signalling: from simple switches to allosteric microprocessors". Nature Reviews. Drug Discovery. 17 (4): 243–260. doi:10.1038/nrd.2017.229. PMC   5936084 . PMID   29302067.
  8. Cahill TJ, Thomsen AR, Tarrasch JT, Plouffe B, Nguyen AH, Yang F, et al. (February 2017). "Distinct conformations of GPCR-β-arrestin complexes mediate desensitization, signaling, and endocytosis". Proceedings of the National Academy of Sciences of the United States of America. 114 (10): 2562–2567. Bibcode:2017PNAS..114.2562C. doi: 10.1073/pnas.1701529114 . PMC   5347553 . PMID   28223524.
  9. Kumari P, Srivastava A, Banerjee R, Ghosh E, Gupta P, Ranjan R, Chen X, Gupta B, Gupta C, Jaiman D, Shukla AK (November 2016). "Functional competence of a partially engaged GPCR-β-arrestin complex". Nature Communications. 7: 13416. Bibcode:2016NatCo...713416K. doi:10.1038/ncomms13416. PMC   5105198 . PMID   27827372.
  10. Kumari P, Srivastava A, Ghosh E, Ranjan R, Dogra S, Yadav PN, Shukla AK (April 2017). "Core engagement with β-arrestin is dispensable for agonist-induced vasopressin receptor endocytosis and ERK activation". Molecular Biology of the Cell. 28 (8): 1003–10. doi:10.1091/mbc.E16-12-0818. PMC   5391177 . PMID   28228552.
  11. Gurevich VV, Gurevich EV (February 2004). "The molecular acrobatics of arrestin activation". Trends in Pharmacological Sciences. 25 (2): 105–11. doi:10.1016/j.tips.2003.12.008. PMID   15102497.
  12. Gurevich EV, Gurevich VV (2006). "Arrestins: ubiquitous regulators of cellular signaling pathways". Genome Biology. 7 (9): 236. doi: 10.1186/gb-2006-7-9-236 . PMC   1794542 . PMID   17020596.
  13. Kang Y, Zhou XE, Gao X, He Y, Liu W, Ishchenko A, et al. (July 2015). "Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser". Nature. 523 (7562): 561–7. Bibcode:2015Natur.523..561K. doi:10.1038/nature14656. PMC   4521999 . PMID   26200343.
  14. Smith JS, Pack TF, et al. (2021). "Noncanonical scaffolding of Gαi and β-arrestin by G protein–coupled receptors". Science. 371 (Ahead of print): eaay1833. doi:10.1126/science.aay1833. PMC   8005335 . PMID   33479120.
  15. Zhang, L. "Rhodopsin phosphorylation sites and their role in S-arrestin binding". PubMed.
  16. Kang, H. "Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser". National Library of Medicine. Retrieved 30 January 2016.
  17. Han M, Gurevich VV, Vishnivetskiy SA, Sigler PB, Schubert C (September 2001). "Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane Translocation". Structure. 9 (9): 869–80. doi: 10.1016/S0969-2126(01)00644-X . PMID   11566136.